Sickle Cell Retinopathy

[1]  Jennifer I. Lim,et al.  Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies. , 2019, American journal of ophthalmology.

[2]  M. Gladwin,et al.  Pathophysiology of Sickle Cell Disease. , 2019, Annual review of pathology.

[3]  Jennifer I. Lim,et al.  Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes. , 2018, American journal of ophthalmology.

[4]  M. Cappellini,et al.  Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula , 2018, PloS one.

[5]  Jonathan S. Chang,et al.  Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy. , 2017, American journal of ophthalmology.

[6]  B. Khan,et al.  Sickle cell retinopathy: improving care with a multidisciplinary approach , 2017, Journal of multidisciplinary healthcare.

[7]  Ian C. Han,et al.  Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy , 2017, PloS one.

[8]  Jing Jin,et al.  Funduscopic examination and SD-OCT in detecting sickle cell retinopathy among pediatric patients. , 2017, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[9]  Mahnaz Shahidi,et al.  Method for quantitative assessment of retinal vessel tortuosity in optical coherence tomography angiography applied to sickle cell retinopathy. , 2017, Biomedical optics express.

[10]  Katia D. Pacheco,et al.  Evaluation of Macular Vascular Abnormalities Identified by Optical Coherence Tomography Angiography in Sickle Cell Disease. , 2017, American journal of ophthalmology.

[11]  Xincheng Yao,et al.  Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography. , 2017, Biomedical optics express.

[12]  G. Semenza,et al.  Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy , 2016, Investigative ophthalmology & visual science.

[13]  Ian C. Han,et al.  CORRELATION OF MULTIMODAL IMAGING IN SICKLE CELL RETINOPATHY , 2016, Retina.

[14]  S. Grover,et al.  Capillary Nonperfusion by Novel Technology of OCT Angiography in a Patient with Sickle Cell Disease with Normal Fluorescein Angiogram , 2016, European journal of ophthalmology.

[15]  E. Souied,et al.  Macular Microangiopathy in Sickle Cell Disease Using Optical Coherence Tomography Angiography. , 2016, American journal of ophthalmology.

[16]  Ian C. Han,et al.  Macular Vascular Abnormalities Identified by Optical Coherence Tomographic Angiography in Patients With Sickle Cell Disease. , 2015, JAMA ophthalmology.

[17]  R. Ware,et al.  Hydroxyurea therapy for sickle cell anemia , 2015, Expert opinion on drug safety.

[18]  A. Ho,et al.  Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy. , 2015, American journal of ophthalmology.

[19]  Mahnaz Shahidi,et al.  Conjunctival microvascular haemodynamics in sickle cell retinopathy , 2015, Acta ophthalmologica.

[20]  M. Moschos,et al.  Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report , 2014, Case reports in ophthalmological medicine.

[21]  William J Savage,et al.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. , 2014, JAMA.

[22]  H. Flynn,et al.  Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series. , 2014, American journal of ophthalmology.

[23]  P. Rosenthal,et al.  Biochemical and immunological mechanisms by which sickle cell trait protects against malaria , 2013, Malaria Journal.

[24]  Jennifer I. Lim,et al.  Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease , 2013, American journal of hematology.

[25]  Winfred C. Wang,et al.  Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children , 2013, British journal of haematology.

[26]  Jennifer I. Lim,et al.  Peripapillary retinal nerve fiber layer thickness in sickle-cell hemoglobinopathies using spectral-domain optical coherence tomography. , 2013, American journal of ophthalmology.

[27]  Jennifer I. Lim.  Ophthalmic manifestations of sickle cell disease: update of the latest findings , 2012, Current opinion in ophthalmology.

[28]  M. Goldberg,et al.  Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management , 2012, TheScientificWorldJournal.

[29]  Jennifer I. Lim,et al.  Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral-domain optical coherence tomography. , 2011, American journal of ophthalmology.

[30]  I. Bechmann,et al.  Sickle Hemoglobin Confers Tolerance to Plasmodium Infection , 2011, Cell.

[31]  Jennifer I. Lim,et al.  Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. , 2011, American journal of ophthalmology.

[32]  S. Kiss,et al.  DETECTION AND MONITORING OF SICKLE CELL RETINOPATHY USING ULTRA WIDE-FIELD COLOR PHOTOGRAPHY AND FLUORESCEIN ANGIOGRAPHY , 2011, Retina.

[33]  K. Hassell.  Population estimates of sickle cell disease in the U.S. , 2010, American journal of preventive medicine.

[34]  O. Babalola.  Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy , 2010, BMJ Case Reports.

[35]  Jonathan D. Powell,et al.  Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. , 2009, The New England journal of medicine.

[36]  T. Williamson,et al.  Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy , 2009, Eye.

[37]  B. Pollock,et al.  National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. , 2008, Annals of internal medicine.

[38]  S. Shaikh.  Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy , 2008, Indian journal of ophthalmology.

[39]  M. Gladwin,et al.  Sickle cell disease vasculopathy: a state of nitric oxide resistance. , 2008, Free radical biology & medicine.

[40]  H. Gill,et al.  A screening strategy for the detection of sickle cell retinopathy in pediatric patients. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[41]  I. Scott,et al.  Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy. , 2006, Acta ophthalmologica Scandinavica.

[42]  J. Duker,et al.  Optical coherence tomography demonstration of macular infarction in sickle cell retinopathy. , 2006, Archives of ophthalmology.

[43]  A. Bird,et al.  Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. , 2005, Ophthalmology.

[44]  K. Eng,et al.  Retinopathy in sickle cell trait: does it exist? , 2003, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[45]  W. Walton,et al.  Management of traumatic hyphema. , 2002, Survey of ophthalmology.

[46]  M L Terrin,et al.  Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. , 1997, Blood.

[47]  J. Meurs.  Evolution of a Retinal Hemorrhage in a Patient With Sickle Cell-Hemoglobin C Disease , 1995 .

[48]  J. Talbot,et al.  New classification of peripheral retinal vascular changes in sickle cell disease. , 1994, The British journal of ophthalmology.

[49]  M. Goldberg,et al.  A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy. A long-term follow-up. , 1991, Ophthalmology.

[50]  L. Jampol,et al.  A randomized clinical trial of scatter photocoagulation of proliferative sickle cell retinopathy. , 1991, Archives of ophthalmology.

[51]  J. Morris,et al.  Risk factors for proliferative sickle retinopathy. , 1990, The British journal of ophthalmology.

[52]  M. Goldberg,et al.  The evolution of salmon-patch hemorrhages in sickle cell retinopathy. , 1989, Archives of ophthalmology.

[53]  T. Savitt,et al.  Herrick's 1910 case report of sickle cell anemia. The rest of the story. , 1989, JAMA.

[54]  J. Clarkson,et al.  Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy. , 1988, Archives of ophthalmology.

[55]  L. Jampol,et al.  A Randomized Clinical Trial of Feeder Vessel Photocoagulation of Proliferative Sickle Cell Retinonathy: II. Update and Analysis of Risk Factors , 1984 .

[56]  L. Jampol,et al.  A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. I. Preliminary results. , 1983, Ophthalmology.

[57]  M. Goldberg,et al.  Chorioretinal and choriovitreal neovascularization. Their presence after photocoagulation of proliferative sickle cell retinopathy. , 1981, Archives of ophthalmology.

[58]  L. Jampol,et al.  Choroidal neovascularisation induced by photocoagulation in sickle cell disease. , 1981, The British journal of ophthalmology.

[59]  G. Serjeant,et al.  Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease. , 1981, The British journal of ophthalmology.

[60]  G. Serjeant,et al.  Behaviour of untreated proliferative sickle retinopathy. , 1980, The British journal of ophthalmology.

[61]  M. Goldberg,et al.  Retinal breaks after photocoagulation of proliferative sickle cell retinopathy. , 1980, Archives of ophthalmology.

[62]  M. Goldberg,et al.  Choroidal occlusive disease in sickle cell hemoglobinopathies. , 1979, Survey of ophthalmology.

[63]  M. Goldbaum,et al.  Cryotherapy of proliferative sickle retinopathy, II: triple freeze-thaw cycle. , 1979, The British journal of ophthalmology.

[64]  M. Goldbaum,et al.  The disc sign in sickling hemoglobinopathies. , 1978, Archives of ophthalmology.

[65]  M. Goldbaum,et al.  Macular holes associated with proliferative sickle cell retinopathy. , 1978, Archives of ophthalmology.

[66]  M. Goldbaum.  Retinal depression sign indicating a small retinal infarct. , 1978, American journal of ophthalmology.

[67]  M. Goldbaum,et al.  Proliferative retinopathy in sickle cell trait. Report of seven cases. , 1977, Archives of internal medicine.

[68]  M. Goldbaum,et al.  Macular and perimacular vascular remodelling sickling haemoglobinopathies. , 1976, The British journal of ophthalmology.

[69]  G. Serjeant,et al.  Ocular findings of elderly cases of homozygous sickle-cell disease in Jamaica. , 1976, The British journal of ophthalmology.

[70]  M. Goldbaum,et al.  Angioid streaks and sickle haemoglobinopathies. , 1976, The British journal of ophthalmology.

[71]  M. Goldbaum,et al.  Evolution of the retinal black sunburst in sickling haemoglobinopathies. , 1975, The British journal of ophthalmology.

[72]  M. Goldberg,et al.  Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. , 1974, Archives of ophthalmology.

[73]  W. Green,et al.  Histopathology of sickle cell retinopathy. , 1973, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.

[74]  G. Serjeant,et al.  Ocular findings in homozygous sickle cell anemia in Jamaica. , 1972, American journal of ophthalmology.

[75]  M. Goldberg,et al.  Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy. , 1971, American journal of ophthalmology.

[76]  M. Goldberg.  Natural history of untreated proliferative sickle retinopathy. , 1971, Archives of ophthalmology.

[77]  M. Goldberg.  Classification and pathogenesis of proliferative sickle retinopathy. , 1971, American journal of ophthalmology.

[78]  R. Welch,et al.  Sickle-cell hemoglobin and its relation to fundus abnormality. , 1966, Archives of ophthalmology.

[79]  D. Paton.  The conjunctival sign of sickle-cell disease. , 1961, Archives of ophthalmology.

[80]  D. Paton.  Angioid Streaks and Sickle Cell Anemia: A Report of Two Cases , 1959 .

[81]  C. Cope,et al.  Intraocular lesions associated with sickle-cell disease. , 1957, A.M.A. archives of ophthalmology.

[82]  J. Hannon.  Vitreous hemorrhages associated with sickle cell-hemoglobin C disease. , 1956, American journal of ophthalmology.

[83]  L. Pauling,et al.  Sickle cell anemia a molecular disease. , 1949, Science.

[84]  J. Herrick,et al.  Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. , 1910, The Yale journal of biology and medicine.

[85]  E. Sigler,et al.  Temporal Macular Atrophy as a Predictor of Neovascularization in Sickle Cell Retinopathy. , 2016, Ophthalmic surgery, lasers & imaging retina.

[86]  A. Scott,et al.  Bevacizumab presurgical treatment for proliferative sickle-cell retinopathy-related retinal detachment. , 2013, Retinal cases & brief reports.

[87]  N. B. Lerner,et al.  Newborn sickle cell screening in a region of Western New York State. , 2009, The Journal of pediatrics.

[88]  L. Jampol,et al.  An update on techniques of photocoagulation treatment of proliferative sickle cell retinopathy , 1991, Eye.